Literature DB >> 26242354

Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.

H Dolatshad, A Pellagatti, M Fernandez-Mercado, B H Yip, L Malcovati, M Attwood, B Przychodzen, N Sahgal, A A Kanapin, H Lockstone, L Scifo, P Vandenberghe, E Papaemmanuil, C W J Smith, P J Campbell, S Ogawa, J P Maciejewski, M Cazzola, K I Savage, J Boultwood.   

Abstract

Entities:  

Year:  2015        PMID： 26242354      PMCID： PMC5780642          DOI： 10.1038/leu.2015.178

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
Correction to: Leukemia (2015) 29, 1092–1103; doi:10.1038/leu.2014.331; published online 23 December 2014. Since the publication of the above article the authors would like to add the following to the Acknowledgements section: AP and JB acknowledge support by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme.
  21 in total

1.  The pre-mRNA splicing and transcription factor Tat-SF1 is a functional partner of the spliceosome SF3b1 subunit via a U2AF homology motif interface.

Authors:  Sarah Loerch; Justin R Leach; Steven W Horner; Debanjana Maji; Jermaine L Jenkins; Mary J Pulvino; Clara L Kielkopf
Journal:  J Biol Chem       Date:  2018-12-19       Impact factor: 5.157

2.  PathwaySplice: an R package for unbiased pathway analysis of alternative splicing in RNA-Seq data.

Authors:  Aimin Yan; Yuguang Ban; Zhen Gao; Xi Chen; Lily Wang
Journal:  Bioinformatics       Date:  2018-09-15       Impact factor: 6.937

3.  Ceramide Analogue SACLAC Modulates Sphingolipid Levels and MCL-1 Splicing to Induce Apoptosis in Acute Myeloid Leukemia.

Authors:  Jennifer M Pearson; Su-Fern Tan; Arati Sharma; Charyguly Annageldiyev; Todd E Fox; Jose Luis Abad; Gemma Fabrias; Dhimant Desai; Shantu Amin; Hong-Gang Wang; Myles C Cabot; David F Claxton; Mark Kester; David J Feith; Thomas P Loughran
Journal:  Mol Cancer Res       Date:  2019-11-19       Impact factor: 5.852

Review 4.  Splicing factor mutations in MDS RARS and MDS/MPN-RS-T.

Authors:  Akihide Yoshimi; Omar Abdel-Wahab
Journal:  Int J Hematol       Date:  2017-05-02       Impact factor: 2.490

Review 5.  The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia.

Authors:  Adam S Sperling; Christopher J Gibson; Benjamin L Ebert
Journal:  Nat Rev Cancer       Date:  2016-11-11       Impact factor: 60.716

Review 6.  Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.

Authors:  Laura M Urbanski; Nathan Leclair; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-04-25       Impact factor: 9.957

Review 7.  The functional mechanisms of mutations in myelodysplastic syndrome.

Authors:  Yasunobu Nagata; Jaroslaw P Maciejewski
Journal:  Leukemia       Date:  2019-10-31       Impact factor: 11.528

8.  Distinct transcriptomic and exomic abnormalities within myelodysplastic syndrome marrow cells.

Authors:  Hogune Im; Varsha Rao; Kunju Sridhar; Jason Bentley; Tejaswini Mishra; Rui Chen; Jeff Hall; Armin Graber; Yan Zhang; Xiao Li; George I Mias; Michael P Snyder; Peter L Greenberg
Journal:  Leuk Lymphoma       Date:  2018-04-04

Review 9.  Aberrant splicing and drug resistance in AML.

Authors:  Rosalia de Necochea-Campion; Geoffrey P Shouse; Qi Zhou; Saied Mirshahidi; Chien-Shing Chen
Journal:  J Hematol Oncol       Date:  2016-09-10       Impact factor: 17.388

10.  Gene Co-Expression Network Analysis Unraveling Transcriptional Regulation of High-Altitude Adaptation of Tibetan Pig.

Authors:  Cunling Jia; Xiaoyan Kong; James E Koltes; Xiao Gou; Shuli Yang; Dawei Yan; Shaoxiong Lu; Zehui Wei
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.